Show simple item record

FieldValueLanguage
dc.contributor.authorPetrides, George Andrew
dc.date.accessioned2026-03-20T01:12:17Z
dc.date.available2026-03-20T01:12:17Z
dc.date.issued2026en
dc.identifier.urihttps://hdl.handle.net/2123/35006
dc.description.abstractSurgical resection of the mandible and maxilla is a standard treatment for jaw pathology, including tumours, trauma, infection, and osteonecrosis. Jaw resection profoundly impacts health-related quality of life (HRQoL) through impairments in aesthetics, speech, swallowing, and mastication. Microvascular free flap reconstruction is the current gold-standard, with adjuncts including virtual surgical planning (VSP) and immediate dental rehabilitation increasingly utilised for their link to improved outcomes. Jaw reconstruction is one of the most resource-intensive procedures in head and neck surgery, yet considerable gaps in the economic literature preclude evidence-based decision-making. This thesis addresses these gaps through five interrelated studies. A scoping review (Study 1) identified 36 studies, finding personnel costs as the primary cost-driver, but only 8% conducted full economic evaluations. Study 2, a micro-costing study of 100 patients, established a mean direct admission cost of A$54,988, with ward staffing, disposables, prostheses/VSP, and operating room staffing as the largest contributors. Study 3, a cost-minimisation analysis of 64 patients, demonstrated that point-of-care VSP (POC-VSP) reduced costs by A$9,835 per case versus commercial VSP, with economies of scale favouring POC-VSP beyond seven cases annually. Study 4, a cost-reimbursement analysis of 61 privately insured patients, found that 93–100% of cases were loss-making when overhead costs were included, with mean deficits of A$26,066–A$49,540, regardless of reimbursement model. Study 5 mapped the FACE-Q Head and Neck Cancer instrument to the EQ-5D-5L using beta regression as the optimal framework, enabling derivation of QALYs from FACE-Q data for future cost-utility analyses. Collectively, this thesis establishes foundational economic evidence to inform clinical decision-making, resource allocation, and health policy for jaw reconstruction.en
dc.language.isoenen
dc.subjecthealth economicsen
dc.subjectmandibular reconstructionen
dc.subjectmaxillary reconstructionen
dc.subjectcostsen
dc.subjectfinancialen
dc.subjectjaw reconstructionen
dc.titleSurgical reconstruction of the mandible and maxilla: A health technology assessment in the Australian contexten
dc.typeThesis
dc.type.thesisDoctor of Philosophyen
dc.rights.otherThe author retains copyright of this thesis. It may only be used for the purposes of research and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission.en
usyd.facultySeS faculties schools::Faculty of Medicine and Healthen
usyd.departmentCentral Clinical Schoolen
usyd.degreeDoctor of Philosophy Ph.D.en
usyd.awardinginstThe University of Sydneyen
usyd.advisorClark, Jonathan
usyd.include.pubNoen


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.